Kyle Romine

Kyle Romine is a highly skilled scientist with extensive experience in cancer research and immunology. Kyle began a career as an Undergraduate Research Assistant at Pacific Northwest National Laboratory from June 2014 to May 2017 under Dr. Aaron Wright. Following that, Kyle pursued advanced studies and earned a Doctor of Philosophy in Cancer Immunology from Oregon Health & Science University between 2017 and 2022, while also contributing as a Graduate Student in T cell differentiation and resistance mechanisms. Kyle's postdoctoral work at Harvard Medical School focused on immune surveillance escape mechanisms in clonal hematopoiesis cells using advanced single-cell technologies. Subsequently, Kyle worked at Seagen as a Scientist, leading the development of targeted antibody-drug conjugate payloads to treat cancer, before transitioning to Pfizer in December 2023 as a Senior Scientist in ADC Payload Discovery. Education includes an Associate of Arts and Sciences from Columbia Basin College and a Bachelor of Science in Biochemistry from Washington State University, both achieved with honors.